Outcomes of 2111 COVID-19 Hospitalized Patients Treated with Hydroxychloroquine/Azithromycin and Other Regimens in Marseille, France, 2020: A Monocentric Retrospective Analysis.

Jean-Christophe LagierMatthieu MillionSébastien CortaredonaLéa DelormePhilippe ColsonPierre-Edouard FournierPhilippe BrouquiDidier RaoultPhilippe Parolanull null

Published in: Therapeutics and clinical risk management (2022)

In our 2020 cohort, treating COVID-19 with HCQ-AZ was associated with lower mortality. These results need to be analyzed in the context of academic discussions about observational studies versus randomized clinical trials. More data will deserve to be analyzed in the SARS-Cov 2 variants, vaccination and post-vaccination era.

Keyphrases

sars cov
coronavirus disease
respiratory syndrome coronavirus
copy number
electronic health record
cardiovascular events
big data
risk factors
type diabetes
adipose tissue
deep learning
medical students
artificial intelligence
insulin resistance
skeletal muscle
glycemic control
data analysis